Association of pediatric asthma severity with exposure to common household dust allergens

Janneane F Gent1, Kathleen Belanger, Elizabeth W Triche

  • 1Yale Center for Perinatal, Pediatric and Environmental Epidemiology, Department of Epidemiology and Public Health, Yale University School of Medicine, One Church Street, 6th Floor, New Haven, CT 06510, USA. janneane.gent@yale.edu

Insights

Reducing exposure to common household dust allergens like dust mite (Der p 1) and pet allergens can decrease asthma severity in children. Higher Der p 1 levels independently increase asthma risk, regardless of allergy status.

Area of Science:

  • Environmental Health
  • Allergology
  • Pediatric Asthma Research

Background:

  • Household dust allergens are implicated in asthma exacerbations.
  • Reducing exposure is a proposed asthma management strategy.
  • Understanding allergen-specific impacts is crucial for targeted interventions.

Purpose of the Study:

  • To investigate dose-response relationships between five common household dust allergens and asthma severity in children.
  • To assess the impact of specific allergens on symptom frequency and medication use.
  • To differentiate effects in atopic versus non-atopic asthmatic children.

Main Methods:

  • A one-year prospective study of 300 asthmatic children (aged 4-12 years).
  • Analysis of household dust for Der p 1, Der f 1, Fel d 1, Can f 1, and Bla g 1.
  • Monthly telephone interviews collected daily symptom and medication data.
  • Statistical models adjusted for demographic factors and specific IgE sensitivity.

Main Results:

  • Elevated Der p 1 (dust mite allergen) concentrations (≥2.0 µg/g) in main living areas and bedrooms correlated with increased asthma severity.
  • Higher pet allergen (cat, dog) levels were linked to greater asthma severity, but only in sensitized children.
  • Der p 1 showed an independent association with asthma severity, irrespective of allergic status.

Conclusions:

  • Higher concentrations of Der p 1 and pet allergens are associated with increased asthma severity in children.
  • Der p 1 is a significant independent risk factor for asthma severity, even when controlling for pet allergens and IgE status.
  • These findings support targeted allergen reduction strategies in pediatric asthma management.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma